Antiangiogenic brassinosteroid compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 17, 2015
Grant Date -
Apr 2, 2015
app pub date -
Dec 14, 2012
filing date -
Dec 15, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method of treating a solid tumor in a mammal by inhibiting angiogenesis, including administering to the mammal which has a solid tumor selected from the group consisting of breast carcinoma, lung carcinoma, prostate carcinoma, colon carcinoma, ovarian carcinoma, neuroblastoma, central nervous system tumor, multiform glioblastoma and melanoma; a composition including brassinosteroids of general formula (I)
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully